MedTrace Logo

Evaluating Disparities in Precision Oncology

NCT06081517 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10600

Last updated 2025-06-13

No results posted yet for this study

Summary

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.

Conditions

Interventions

BEHAVIORAL

Social Determinants of Health and toxicity questionnaires

Collect detailed clinical, and social data from patients to identify significant contributors of disparate survival and toxicity outcomes.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Bryan P Schneider, MD · Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-26
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06081517 on ClinicalTrials.gov